Jefferies Downgrades GoodRx Holdings to Hold, Lowers Price Target to $2.75
Benzinga Newsdesk 9 months ago
NewsDowngradesPrice TargetAnalyst Ratings
Jefferies analyst Glen Santangelo downgrades GoodRx Holdings (NASDAQ:GDRX) from Buy to Hold and lowers the price target from $5.25 to $2.75.
Jefferies analyst Glen Santangelo downgrades GoodRx Holdings (NASDAQ:GDRX) from Buy to Hold and lowers the price target from $5.25 to $2.75.